Latest News
Jagsonpal Pharmaceuticals Limited
- Jagsonpal Pharmaceuticals (JAGSNPHARM.NS) Edges Higher to ₹219.52, Holds Above Key Support of ₹208.54 - Break of Structure
- Jagsonpal Pharmaceuticals vs Nifty 50: Returns Compared
- Is Jagsonpal Pharmaceuticals the Best Stock in Its Sector? A Look at the Numbers
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolio for Rs. 46.7 Cr
- Jagsonpal Pharmaceuticals to Acquire Group Pharma Wellness Portfolio
- Delhi-Based Jagsonpal Pharma to Acquire Group Pharmaceuticals' Wellness Portfolio for Up to Rs 46.7 Crore
- Jagsonpal Pharma to acquire Group Pharma’s wellness portfolio
- Convergent-backed Jagsonpal, BlueBinaries, Macquarie's Blueleaf ink M&As
- Jagsonpal Pharma to acquire Group Pharmaceuticals' wellness portfolio
- Jagsonpal Pharmaceuticals Share Price Rises 9.87% Today
- Jagsonpal Pharmaceuticals Ltd (NSE: JAGSNPHARM) Acquires Wellness Portfolio for ₹46.7 Crore
- Jagsonpal Pharma to Buy Group Pharma’s Wellness Portfolio for Up to ₹46.7 Crore
Headlines from the last 30 days, linking to the original publishers. See all market news →